fda approved semaglutide compound The Risks of Compounded Products Shed GLP-1 Review 2026 Explores

Check out my podcast on protein to understand why quality matters

doi: 10.1111/head.14426

Wegovy and Zepbound are the most reported medications: 45% of all shortage reports are for Wegovy 34% of all shortage reports are for Zepbound 19% of all shortage reports are for Ozempic and Mounjaro, GLP-1s indicated for type-2 diabetes Starter doses are the most often reported: Wegovy 0.25mg is the most commonly reported dosage, appearing in about twice as many reports as other Wegovy doses

What UK law says The short version: none of these are licensed medicines in the UK, and supplying any of them for human use without a marketing authorisation is unlawful under the Human Medicines Regulations 2012